Characteristic

SOF+ DAC (n= 95)

SOF+DAC+RBV (n= 32)

Demographic characteristics

Age (M, SD)

47,8 ± 9,6

45,6 ± 11,5

Male, n (%)

50 (52,6%)

17 (53,1%)

Diabetes n (%)

4 (4,2%)

3 (9,4%)

Hypertension, n (%)

9 (9,5%)

1 (3,1%)

HCV disease-related characteristics

Traitement naïve, n (%)

94 (98,9%)

-

Treatement-experienced, n (%)

-

7 (21,9%)

Genotype, n (%)

1

1 (1,1%)

3 (9,4%)

1a

8 (8,4%)

2 (6,3%)

1b

9(9,5%)

4 (12,5%)

2a

22 (23,2%)

10 (31,3%)

2b

4 (4,2%)

-

2a/2c

16 (16,8%)

6 (18,8%)

2c

1 (1,1%)

1 (3,1%)

2d

1 (1,1%)

-

2e

1 (1,1%)

-

2m

2(2,1%)

-

Unknown genotype

1 (1,1%)

1(3,1%)

2 unknown subtype

27 (28,4%)

4 (12,5%)

4

2 (2,1%)

1 (3,1%)

Plasma VHC RNA, log₁₀ IU/ml, (M, SD)

5,81±0,76

5,84±0,69

Cirrohosis, N (%)

Absent

30 (31,6%)

4 (12,5%)

Not reported

65 (68,4%)

26 (81,3%)

Present

-

2 (6,3%)

ALT (M, SD)

46,3±33,7

43,2±24,8

AST (M, SD)

43,2±35,4

42,2±38,4

Albumin (M, SD)

53,7±10,2

49,2±10,8

Total Bilirubin (M, SD)

11,7±1,4

11,9±0,4

Platelets count (M, SD)

155±342

159±321